OGEN Oragenics Inc

Price (delayed)

$0.5

Market cap

$2.26M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.97

Enterprise value

-$3.79M

?
Relative Growth: Rel. Growth: 3
Relative Strength: Rel. Strength: 9
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 4

Oragenics is a development-stage biotechnology company focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI), also ...

Highlights
The debt has dropped by 98% year-on-year and by 75% since the previous quarter
Oragenics's net income has increased by 4.9% YoY
OGEN's EPS has dropped by 121% year-on-year and by 9% since the previous quarter
Oragenics's equity has decreased by 25% from the previous quarter

Key stats

What are the main financial stats of OGEN

OGEN stock price

How has the Oragenics stock price performed over time
Intraday
0%
1 week
-0.2%
1 month
-14.53%
1 year
-60%
YTD
-36.16%
QTD
-13.88%

Financial performance

How have Oragenics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.59M
Net income
-$9.83M
Gross margin
N/A
Net margin
N/A
Oragenics's net income has increased by 4.9% YoY
OGEN's operating income is up by 5% year-on-year but it is down by 2.5% since the previous quarter

Price vs fundamentals

How does OGEN's price correlate with its fundamentals

Growth

What is Oragenics's growth rate over time

Valuation

What is Oragenics stock price valuation
P/E
N/A
P/B
0.35
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
OGEN's EPS has dropped by 121% year-on-year and by 9% since the previous quarter
The P/B is 90% less than the 5-year quarterly average of 3.5
Oragenics's equity has decreased by 25% from the previous quarter

Efficiency

How efficient is Oragenics business performance
OGEN's ROE has soared by 81% YoY and by 27% from the previous quarter
OGEN's ROA has soared by 61% year-on-year and by 11% since the previous quarter
The company's return on invested capital rose by 43% QoQ

Dividends

What is OGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OGEN.

Financial health

How did Oragenics financials performed over time
The total assets has soared by 94% YoY but it has contracted by 26% from the previous quarter
The total liabilities has plunged by 65% YoY and by 27% from the previous quarter
The debt is 99% smaller than the equity
OGEN's debt to equity has shrunk by 100% YoY and by 67% QoQ
The debt has dropped by 98% year-on-year and by 75% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.